XML 50 R53.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Details Textual) (USD $)
0 Months Ended 12 Months Ended
Oct. 16, 2013
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Stock Based Compensation (Textual) [Abstract]        
Stock-Based Compensation expense     $ 22,000 $ 196,000
Recognized tax benefits     9,000 80,000
Increase in number of common stock shares authorized 233,334      
Percentage to retain annual restricted stock awards 50.00%      
Stock options exercise price description   May not be exercised at a price which is less than 100% of the fair market value of shares at the date of grant.    
Stock options grant term   10 years    
Intrinsic value of stock options exercised   155,500 72,200  
Proceeds from stock options exercised   311,500 287,600  
Weighted average grant date fair value of restricted stock that vested during   99,000 159,000 333,000
Net value of unrecognized compensation cost related to unvested restricted stock awards   2,210,000 16,000 127,000
Restricted stock [Member]
       
Stock Based Compensation (Textual) [Abstract]        
Stock-Based Compensation expense   135,000 110,000 187,000
Recognized tax benefits   $ 53,000 $ 45,000 $ 77,000
Common Class A [Member] | Convert For Class B [Member]
       
Stock Based Compensation (Textual) [Abstract]        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 280,000      
Common Class A [Member] | Stock Option [Member]
       
Stock Based Compensation (Textual) [Abstract]        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 900,000      
Common Class A [Member] | Incentive Compensation Plan [Member]
       
Stock Based Compensation (Textual) [Abstract]        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 620,000      
Common Class B [Member] | Stock Option [Member]
       
Stock Based Compensation (Textual) [Abstract]        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 280,000